Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a majority stake in the clinical-stage company and replacing its CEO.

Vision care made up 43% of fiscal 2023 total ... Thanks to these high-performing products and its brand power, Alcon has been able to achieve over 80% and 55% of the domestic and global presbyopia ...